InsidersTradesSigma
Track the 삼성에피스홀딩스 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 삼성에피스홀딩스 has published 12 reports. Market capitalisation: €8,659.3bn. The latest transaction was filed on 1 April 2026 (Sale). Among the most active insiders: 삼성에피스홀딩스. All data is openly available.
Analysts rate 삼성에피스홀딩스 Buy (bullish), based on 2 analysts. Average price target: ₩600,000.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
12 of 12 declarations
Samsung Epise Holdings is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on the development and commercialization of innovative pharmaceutical products.